Kalkine has a fully transformed New Avatar.
Orthocell generates its first U.S. revenue from flagship nerve repair product, Remplir™.
Artrya signs five-year commercial SaaS agreement with Tanner Health, valued at US$0.6 million.
Highlights
ASX 200 rises 0.6% to 8,587.70, led by banks, miners, and tech stocks.
ACCC approves Lactalis' acquisition of Fonterra’s Australian consumer, dairy ingredients, and foodservice businesses.
Netwealth achieved a record AUD 15.8 billion in FUA net flows in FY25, up 40% year-on-year.
Imagion Biosystems shares jumped 44% to AUD 0.018 on 10 July 2025 following regulatory progress.
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine! Start Your 7-Days Free Trial Today!
Continue
AU
CA
NZ
UK
US
IND
Please wait processing your request...